Chemomab Therapeutics (2QV) Q2 2026 Earnings Report
1 Followers
DE:2QV Q2 2026 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.13
- Beat/Miss
- Beat by +EUR 0.13
- One Year Ago EPS
- -EUR 0.01
DE:2QV Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/19/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 19, 2026
DE:2QV Upcoming Earnings
Chemomab Therapeutics's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2QV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Nov 06, 2026 | 2026 (Q3) | 0.00- | -0.01 | ― | |
| Aug 19, 2026 | 2026 (Q2) | -0.13-0.00 | -0.01 | 81.25% (+0.01) | |
| May 14, 2026 | 2026 (Q1) | 0.00-0.00 | -0.02 | 89.29% (+0.02) | |
| Mar 19, 2026 | 2025 (Q4) | -0.04-0.00 | -0.03 | 90.63% (+0.03) | |
| Nov 20, 2025 | 2025 (Q3) | -0.04-0.01 | -0.04 | 60.00% (+0.02) | |
| Aug 14, 2025 | 2025 (Q2) | -0.04-0.01 | -0.05 | 69.23% (+0.03) | |
| May 15, 2025 | 2025 (Q1) | -0.04-0.02 | -0.05 | 50.00% (+0.02) | |
| Mar 03, 2025 | 2024 (Q4) | -0.04-0.03 | -0.05 | 38.46% (+0.02) | |
| Nov 14, 2024 | 2024 (Q3) | -0.04-0.04 | -0.06 | 41.18% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
